Warrant
Issued 2022
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: CHExchange: NYSE
DilutionScan read 36 of ADC Therapeutics SA's SEC filings and found 6 warrant series, 1 ATM program, 4 shelf registrations and 2 completed offerings on file for ADCT. Analysis updated Oct 18, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 27 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Oct 7, 2026 · Offering Priced
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2022
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2024
Total capacity
Sold to date
Issued 2024
Total capacity
Remaining
Issued 2025
Total capacity
Remaining
Issued 2025
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2025
Gross proceeds
Price per share
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z